Parkinson Weekly

🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader implications for global Parkinson’s care.👉 You can read the full article below:https://pubmed.ncbi.nlm.nih.gov/41269916/Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎄🎙️ We’re back with a special Christmas bonus episode of Parkinson Weekly, hosted by Prof. Bas Bloem.In this festive episode, Bas reflects on the many developments, conversations, and lessons from 2025, offering a thoughtful and wide-ranging look at where Parkinson’s disease research and care stand today. From scientific progress and clinical practice to people, policy, and purpose, he shares his perspective on what has changed — and what still needs to evolve. Bas also looks ahead to the future, outlining his outlook on Parkinson’s disease treatment in the years to come, with a message of realism, optimism, and continued collaboration as we move into the next chapter.Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the fifteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.In this week’s episode, Bas explores the next generation of neuromodulation with a focus on Adaptive Deep Brain Stimulation (aDBS), joined by special guest Dr. Martijn Beudel. Together, they unpack how aDBS moves beyond traditional continuous stimulation by dynamically responding to a patient’s brain signals in real time. The discussion highlights the potential of this personalised approach to improve symptom control, reduce side effects, and reshape the future of Parkinson’s disease treatment, while also addressing the clinical challenges and research still needed to bring aDBS into wider practice.Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the fourteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.In this week’s episode, Bas delves into the rapidly evolving world of artificial intelligence and its growing influence on Parkinson’s disease care and healthcare in general. He explores how AI-driven tools offer remarkable new possibilities — from earlier diagnosis to personalised treatment strategies — while also highlighting the ethical, clinical, and practical concerns that come with relying on algorithms in healthcare. Bas reflects on how the promise of AI must be balanced with caution, transparency, and rigorous scientific validation.Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the thirteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.In this week’s episode, Bas explores the powerful intersection between art and Parkinson’s disease — how creativity, expression, and the artistic process can offer unique insights into living with the condition. From movement and emotion to identity and resilience, Bas reflects on the ways art can illuminate aspects of Parkinson’s that clinical measures often overlook.The article of the week, “Shades of grey: The continuum of therapies for Parkinson’s disease along the spectrum of credibility” dives into the nuanced landscape of Parkinson’s treatments. Bas discusses how different therapeutic approaches — from well-established evidence-based interventions to emerging and unconventional options — fit along a continuum, and why understanding this spectrum is essential for both clinicians and people with Parkinson’s.👉 You can read the full article below:https://pubmed.ncbi.nlm.nih.gov/40746025/Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.